- Home
- AMS vs HOTH Comparison
AMS vs HOTH Comparison
Compare AMS & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- HOTH
- Stock Information
- Founded
- AMS 1980
- HOTH 2017
- Country
- AMS United States
- HOTH United States
- Employees
- AMS N/A
- HOTH N/A
- Industry
- AMS Medical Specialities
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- AMS Health Care
- HOTH Health Care
- Exchange
- AMS Nasdaq
- HOTH Nasdaq
- Market Cap
- AMS 18.3M
- HOTH 15.6M
- IPO Year
- AMS N/A
- HOTH 2019
- Fundamental
- Price
- AMS $2.41
- HOTH $1.34
- Analyst Decision
- AMS
- HOTH Strong Buy
- Analyst Count
- AMS 0
- HOTH 3
- Target Price
- AMS N/A
- HOTH $4.00
- AVG Volume (30 Days)
- AMS 17.1K
- HOTH 659.0K
- Earning Date
- AMS 08-13-2025
- HOTH 05-12-2025
- Dividend Yield
- AMS N/A
- HOTH N/A
- EPS Growth
- AMS 151.01
- HOTH N/A
- EPS
- AMS 0.21
- HOTH N/A
- Revenue
- AMS $29,236,000.00
- HOTH N/A
- Revenue This Year
- AMS $23.63
- HOTH N/A
- Revenue Next Year
- AMS N/A
- HOTH N/A
- P/E Ratio
- AMS $11.35
- HOTH N/A
- Revenue Growth
- AMS 35.25
- HOTH N/A
- 52 Week Low
- AMS $2.27
- HOTH $0.58
- 52 Week High
- AMS $4.60
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- AMS 46.24
- HOTH 61.16
- Support Level
- AMS $2.39
- HOTH $1.38
- Resistance Level
- AMS $2.49
- HOTH $1.57
- Average True Range (ATR)
- AMS 0.13
- HOTH 0.09
- MACD
- AMS 0.00
- HOTH 0.01
- Stochastic Oscillator
- AMS 18.67
- HOTH 67.39
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).